IOmx Therapeutics raised €40M in a Series A round in Sep 2016. The company is based in Munich, Germany. Investors in the round: Merck Ventures, MPM Capital, Sofinnova Partners and 1 other. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €40M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
